Elicio Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
09 Apr 24 | SellUS$927,470 | Clal Biotechnology Industries Ltd. | Company | 117,470 | US$9.44 | |
19 Mar 24 | SellUS$537,524 | Clal Biotechnology Industries Ltd. | Company | 82,696 | US$6.50 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 2,045 | 0.02% |
Public Companies | 199,564 | 1.95% |
Institutions | 812,879 | 7.95% |
General Public | 4,576,066 | 44.8% |
Individual Insiders | 4,630,460 | 45.3% |
Dilution of Shares: ELTX only recently listed within the past 12 months
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
2,595,072 | US$25.0m | 0% | no data | |||
1,915,639 | US$18.5m | 0% | no data | |||
416,570 | US$4.0m | -33.3% | 42.13% | |||
215,686 | US$2.1m | 23.3% | no data | |||
199,564 | US$1.9m | 0% | no data | |||
119,749 | US$1.2m | 0% | no data | |||
50,000 | US$482.5k | -23.1% | 0.43% | |||
44,344 | US$427.9k | 59.1% | no data | |||
16,466 | US$158.9k | 0% | no data | |||
14,005 | US$135.1k | -13.6% | no data | |||
13,899 | US$134.1k | 0% | no data | |||
12,500 | US$120.6k | 0% | no data | |||
9,997 | US$96.5k | 0% | 0.45% | |||
7,000 | US$67.6k | 0% | no data | |||
5,314 | US$51.3k | -11.6% | no data | |||
2,363 | US$22.8k | 0% | no data | |||
2,045 | US$19.7k | 5,280% | no data | |||
1,554 | US$15.0k | 0% | no data | |||
1,146 | US$11.1k | 0% | no data | |||
917 | US$8.8k | 0% | no data | |||
374 | US$3.6k | 0% | no data | |||
350 | US$3.4k | 0% | no data | |||
157 | US$1.5k | 0% | no data | |||
78 | US$749.6 | 36.8% | no data | |||
78 | US$749.6 | 0% | no data |